Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.
Gut flora and bacterial translocation (BT) play important roles in the pathogenesis of chronic liver disease, including cirrhosis and its complications. Intestinal bacterial overgrowth and increased bacterial translocation of gut flora from the intestinal lumen predispose patients to bacterial infections, major complications and also play a role in the pathogenesis of chronic liver disorders. Levels of bacterial lipopolysaccharide, a component of gram-negative bacteria, are increased in the portal and/or systemic circulation in several types of chronic liver disease. Impaired gut epithelial integrity due to alterations in tight junction proteins may be the pathological mechanism underlying bacterial translocation. Preclinical and clinical studies over the last decade have suggested a role for BT in the pathogenesis of nonalcoholic steatohepatitis (NASH). Bacterial overgrowth, immune dysfunction, alteration of the luminal factors, and altered intestinal permeability are all involved in the pathogenesis of NASH and its complications. A better understanding of the cell-specific recognition and intracellular signaling events involved in sensing gut-derived microbes will help in the development of means to achieve an optimal balance in the gut-liver axis and ameliorate liver diseases. These may suggest new targets for potential therapeutic interventions for the treatment of NASH. Here, we review some of the mechanisms connecting BT and NASH and potential therapeutic developments.
Gastroenterology and Liver Units, Department of Medicine, Hadassah Hebrew University Medical Center, Jerusalem 91120, Israel. ilan@hadassah.org.il
Yaron
Y
Ilan
D000818:Animals; D001419:Bacteria / Q000378:metabolism*; D018988:Bacterial Translocation / Q000276:immunology*; D004926:Escherichia coli / Q000378:metabolism; D005234:Fatty Liver / Q000276:immunology / Q000382:microbiology*; D005355:Fibrosis / Q000382:microbiology; D006801:Humans; D007107:Immune System; D007333:Insulin Resistance; D007413:Intestinal Mucosa / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008954:Models, Biological; D019108:Tight Junctions / Q000378:metabolism; D051193:Toll-Like Receptors / Q000378:metabolism
D008070:Lipopolysaccharides; D051193:Toll-Like Receptors